RBM5 and non-small cell lung carcinoma: In the present study, we found that hsa_circ_0003176 suppressed the NSCLC progression via regulating miR-182-5p/RBM5 axis, and these findings indicated that hsa_circ_0003176 might be a novel molecular target for NSCLC treatment.